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Abstract: This study used a system evaluation method to summarize
China’s experience on improving the coverage of hepatitis B vaccine,
especially the strategies employed to improve the uptake of timely birth
dosage. Identifying successful methods and strategies will provide
strong evidence for policy makers and health workers in other countries
with high hepatitis B prevalence.
We conducted a literature review included English or Chinese
literature carried out in mainland China, using PubMed, the Cochrane
databases, Web of Knowledge, China National Knowledge Infrastruc-
ture, Wanfang data, and other relevant databases.
Nineteen articles about the effectiveness and impact of interventions
on improving the coverage of hepatitis B vaccine were included. Strong
or moderate evidence showed that reinforcing health education, training
and supervision, providing subsidies for facility birth, strengthening the
coordination among health care providers, and using out-of-cold-chain
storage for vaccines were all important to improving vaccination
coverage.
We found evidence that community education was the most com-
monly used intervention, and out-reach programs such as out-of-cold
chain strategy were more effective in increasing the coverage of
vaccination in remote areas where the facility birth rate was respectively
low. The essential impact factors were found to be strong government
commitment and the cooperation of the different government
departments.
Public interventions relying on basic health care systems combined
with outreach care services were critical elements in improving the
hepatitis B vaccination rate in China. This success could not have
occurred without exceptional national commitment., Biao Xu, and Weibing Wang, MD, PhD
HBV = hepatitis B virus, MoH = Ministry of Health, TBD = timely
birth dose, WHO = World Health Organization.
INTRODUCTION
H epatitis B is a viral infection, spread through blood andbodily fluids, which infects the liver. According to the
World Health Organization (WHO) approximately 2 billion
people currently are infected by hepatitis B virus (HBV), and an
estimated 240 million people are chronic HBV carriers.1 More
than 780,000 people die every year due to the consequences of
HBV such as hepatic failure, cirrhosis of the liver, and liver
cancer.2 Hepatitis B is especially a serious problem in devel-
oping countries due to the high infection rate. In China, the
National Sero Epidemiological Survey of Hepatitis B in 2006
indicated that the HBV carrier rate was 7.8% in the national
population,3 and in 2012, the prevalence was as high as 80.7 per
100,000,4 making China a high endemic area. In the last few
years, more and more data have been produced in developing
countries where the most common route of infection is still
vertical transmission from mother to child.5 About 80% to 90%
of infants infected during the 1st year of life and 30% to 50% of
children infected before the age of 6 years develop chronic
infection. Since 15% to 25% of adults who become chronically
infected during childhood die from hepatitis B-related liver
cancer or cirrhosis,2 prevention of mother-to-child disease
transmission has been crucial to reducing prevalence.
Safe and effective vaccines exist to prevent infection with
HBV, and the WHO recommends all infants receive a first
vaccine dose within 24 hours of birth to protect against HBV
infection.6 By the end of 2013, although global coverage with
3 doses of hepatitis B vaccine was estimated at 81% and as high
as 92% in the Western Pacific, global coverage with a birth dose
for hepatitis B vaccine was estimated at 38%, only 11% in the
African Region.7
China has made great progress with universal vaccination
for hepatitis B; the latest data from WHO suggests over 95% of
newborns receive a timely birth dose (TBD) of hepatitis B
vaccine.8 The vaccine was introduced in 1987, and in 1992 the
Chinese government established the National Hepatitis B
Immunization Plan,9 which recommended timely first dose
within 24 hours of birth and subsequent doses at ages 1 and
6 months.10 However, user fees charged to parents by local
health departments for vaccine purchase and administration
were serious barriers to uptake at this time.11 In 2002, the
Global Alliance on Vaccine and Immunization (GAVI) part-
nered with the Government of China to provide hepatitis B
vaccine for free and cap user fees to ensure affordability.12 By
2005, hepatitis B vaccination of infants was fully integrated into
the routine immunization programme and provided completely
free of charge nationally.13 As a result of these policies, thee tripled from 30.0% for children born in
dren born in 2012, and receipt of a TBD
to 95.7% for children born during this
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interval. Most importantly, the carrier rate in Chinese children
less than 5 years of age fell to 0.96% in 2006, and further to
0.32% in 2014 (from 10% in the 1990s);14 this reduction of 90%
meets the targets set by the WHO.15 Many women of child-
bearing age in China today were born before hepatitis B vaccine
was fully integrated into the routine immunization policy, so the
Government has acted to try to sustain reductions in prevalence
of hepatitis B infection. In 2010 the Ministry of Health (MoH)
recommended screening of all pregnant women for hepatitis B
surface antigen and vaccination and hepatitis B immunoglobu-
lin administration within 24 hours of birth for all infants born to
hepatitis B surface antigen positive mothers.12
Since the introduction of the first national policy on
Hepatitis B vaccination, the government of China has employed
many strategies to improve coverage of the timely first dose and
subsequent doses for infants. For example, increasing the
percentage of births that occur in hospitals, improving vaccine
availability in health facilities, building collaboration between
different departments, increasing the awareness of the import-
ance of TBD administration, and providing subsidies to village
doctors to provide vaccines.
There may be important lessons from China for other
countries where coverage of hepatitis B vaccination lags behind
and targets remain unmet. We conducted a systematic review of
the literature on China’s experience in improving the coverage
of hepatitis B vaccine, especially strategies to improve the
uptake of TBD. We sought to address 3 main questions: what
interventions or strategies have been used in China to increase
hepatitis B vaccination coverage?; is there any evidence of
Wang et alimpact of strategies or interventions on vaccination coverage?;
and what can we learn about factors influencing successful
implementation of interventions in China?
METHODS
Selection Criteria
This systematic review only included English or Chinese
studies and reports carried out in mainland China. For our
objective relating to the strategies used in China, we included
any study design including program evaluations and review
papers. For our objective relating to the impact of interventions,
we included original research, using any randomized or non-
randomized design that assessed outcomes relating to vaccine
coverage (number of children fully immunized with 3 doses,
or number of infants receiving TBD of vaccine). To address
our objective about implementation experiences, we included
TABLE 1. Inclusion Criteria and Data Extracted
Question Inclusion C
What interventions or strategies have
been used in China to increase
hepatitis B vaccination coverage?
Any study design, eval
paper
Is there any evidence of impact of
strategies or interventions on
vaccination coverage rates?
Any randomised or non
What can we learn about factors
influencing successful
implementation of the interventions
in China?
Any empirical research
or mixed methods tha
influencing impleme
interventions to imp
hepatitis B vaccinati
2 | www.md-journal.comresearch or descriptions of the facilitators or barriers to imple-
menting strategies or interventions to increase vaccination
coverage or uptake. Studies that involved multiple vaccines
were also accepted, as long as one of the vaccines was for
hepatitis B (see Table 1).
Studies were excluded if: 1) the study was restricted to
efficacy of the vaccine or other treatment to mothers or the
neonates, without analysis of impact factors on vaccine cover-
age; 2) there was no clear source(s) of evidence or a research
method; 3) full-text version was not accessible.
Search Strategy
We searched PubMed, EMBASE, the Cochrane Database
of Systematic Reviews, Web of Knowledge, China National
Knowledge Infrastructure, and Wanfang data for all relevant
studies published in English or Chinese from post-1992
when the first national plan was implemented up to December
24th, 2014. Keywords used were ‘‘HBV’’ OR ‘‘hepatitis B,’’
‘‘vaccination’’ OR ‘‘immunization,’’ ‘‘coverage,’’ ‘‘mother to
child’’ OR ‘‘mother to infant’’ OR ‘‘vertical’’ OR ‘‘prenatal
transmission’’ OR infant OR ‘‘new-born,’’ and ‘‘China’’ OR
‘‘Chinese’’ (see Supplementary Table S1, http://links.lww.com/
MD/A976 Supplemental Content, which showed an example
search strategy used to search PubMed). The strategy was
adjusted as necessary for other electronic databases. We also
examined reference lists of relevant studies and reviews to
identify additional relevant papers.
The first author screened titles and abstracts generated
from the initial search to exclude those studies not directly
meeting the inclusion criteria. Following this, 2 authors inde-
pendently screened the full texts in order to select studies
relevant to our objectives. Uncertainties and disagreements
during all the process were resolved through discussion with
coauthors.
Quality Assessment of Included Studies
Each study included in the review that provided data on
impact (n¼ 19) was appraised using quality-assessment tool
developed by the Effective Public Health Practice Project in
Canada.16 The Effective Public Health Practice Project is a
widely used tool used to evaluate a variety of study designs
including randomized controlled trials, before-and-after and
case–control studies. The tool assesses 6 components according
Medicine  Volume 95, Number 19, May 2016to its dictionary: selection bias, study design, confounders,
blinding, data collection method, and withdrawals/dropouts.17
Each component is rated as strong (3 points), moderate
riteria Data Extracted
uation, or review Characteristics of programmes or
interventions to improve coverage
of hepatitis B vaccination
randomized design Data on outcomes relating to vaccine
coverage
using qualitative
t reports on factors
ntation of
rove coverage of
on
Knowledge, skills, and attitudes
among recipients of care, providers
of care, and other stakeholders;
health service and system factors;
and social and political constraints
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(2 points), or weak (1 point), and component scores are aver-
aged to provide the total score.16 Studies are assigned a global
rating result of weak (1.00–1.50), moderate (1.51–2.50), or
strong (2.51–3.00) based on the total score.18
Synthesis
The first author extracted information on the character-
istics of each included study, using a standard form, and at the
same time categorized the studies into those that reported
national programmes and those that described provincial pro-
jects. We used a systematic narrative approach to summarize
key characteristics of interventions or strategies to increase
hepatitis B vaccination coverage, including the study design,
participants, type of intervention, intervention components, and
outcomes reported (see Table 2). We described interventions
and categorized them based on the system used by the Cochrane
Review of interventions to improve coverage of childhood
vaccinations.19 Patient- or community-oriented interventions
included public health education targeted toward pregnant
women and their families. Provider-oriented interventions
included health education, update courses, or training for health
care providers to improve their awareness and responsibility for
administering timely first dose and subsequent doses as well as
more specific interventions targeting provider behavior includ-
ing payment and incentives/punishment and improved monitor-
ing and supervision. Health system interventions are those
designed to improve the quality of vaccine delivery services
or access to services via central and local policies, laws,
regulations, and guidelines for improving immunization cover-
age or reducing disease; integration of immunization services
with other services; interventions to improve the quality of
services; centralized registration; and management system for
all pregnant women. We categorized strategies as ‘‘multiple
levels’’ if they included any combination of these different
levels. As the included studies reported on different strategies or
combinations of interventions, used various designs and
methods, and reported on different outcomes we used a narra-
tive approach to summarize data on the impact of strategies or
interventions on vaccination coverage rates. Data on coverage
of TBD, TBD in home births, or 3 doses of vaccine summarized
this in a table to show impact of strategies or interventions on
vaccination coverage rates (Table 3).
To help extract relevant information on factors influencing
successful implementation we used a proforma adapted from
the SURE framework,20 used in other reviews of this nature.21
The framework offers a comprehensive list of possible factors
affecting implementation of health system interventions,
including knowledge, skills and attitudes among recipients of
care, providers of care, and other stakeholders; health service
and system factors; and social and political constraints. We
extracted findings from the results and discussion sections of
included studies into the framework and reviewed these for
relevance and consistency. The whole team discussed the con-
tent and meaning of emerging themes and decided on final
themes to present.
The authors did not access any individual information and
had no interactions with the patients involved in this study. So,
neither ethics review nor informed consent was required for the
current analysis.
RESULTS
Medicine  Volume 95, Number 19, May 2016We identified 2100 papers from the electronic search and
9 papers from reference lists. A total of 1438 titles and abstracts
were considered after duplicate records were removed, and of
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.these, 305 full-text articles were assessed for eligibility. A
further 286 were excluded as it was difficult to determine
the study design or methods used to assess impact. A total of
19 papers were included in the synthesis. The study selection
process is shown in Figure 1.
Study designs included before–after studies (n¼ 7), clus-
ter randomization trials (n¼ 4), program evaluations (n¼ 5),
and reviews (n¼ 3). Eight papers were published in English and
11 in Chinese. Of the 19 included studies14,15,22–33 reported on
multiple strategies employing a combination of interventions to
improve coverage of hepatitis B vaccination; four34–37 reported
on health system interventions and only one38 reported patient/
community-oriented interventions. All these included studies
contain information about implementation factors too. Table 2
shows the characteristics of the included studies.
QUALITY OF INCLUDED STUDIES
No study was rated as ‘‘strong,’’ and most, including all 4
cluster randomization trials, were rated ‘‘moderate.’’ One
before-and-after study and 1 programme evaluation were rated
‘‘weak.’’ For both the randomized controlled trials and before-
and-after studies, the main limitations were the lack of blinding
and no description of methods of randomization. Since most of
the data were derived from routine reports, the outcome asses-
sors were usually aware of the intervention status of participants
in the projects and since education or other interventions were
usually community-based, the study participants were aware of
the research objectives.
WHAT INTERVENTIONS HAVE BEEN
TRIED IN CHINA?
National Programmes
Among the 19 included studies, 5 including 3 reviews and
2 program evaluations described programmes implemented at
national level.14,15,23,29,33 The all programmes used multiple
interventions or strategies to achieve the targets. Kane et al14
and Liang et al29 both described the GAVI funded project, while
Kane focused more on the political and social context and the
inception of the project on the health system level and Liang
described mainly the exact strategies involved in the project.
The GAVI programme was designed to increase the coverage of
hepatitis B vaccination in poor rural areas through health
education to increase the awareness of the parents, training
for health providers and health workers, improving the number
of women giving birth in hospital, and key government policies
requiring ‘‘who deliver the infant, who has to vaccinate the
infant.’’ Most important of all, the government invested equal
funding with GAVI to remove the cost of vaccination and added
hepatitis B vaccine into the routine immunization schedule.
Zhou et al33 reviewed hepatitis B vaccine used in China and the
impact of the vaccination implementation from 1980 to 2008.
The strategies mentioned in the review included reinforcing
health education, training, improving transportation to increase
the facility birth rate, strengthening the coordination between
different groups, regular vaccine distributions to remote areas,
and using of auto-disposable (AD) syringes.33 Liang et al15
described the results of the National Sero Epidemiological
Survey of Hepatitis B in 2006 and evaluated the impact of
integrating hepatitis B vaccine into the National Immunization
Experiences in China’s Hepatitis B Vaccination ImplementationProgram and providing vaccination for all infants for free. Cui
et al23 reported China’s progress in increasing coverage among
infants with universal infant hepatitis B vaccination, which
www.md-journal.com | 3
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2100 records identified 
through database 
searching
9 records identified 
through reference
1133 records excluded 
(irrelevant subject, study of 
only the efficacy of the 
vaccine) 
305 of full-text articles 
assessed for eligibility
286 full-text articles excluded 
due to study design/ outcome 
measures or duplicate studies
1438 titles and abstracts 
screened after duplicate 
records were removed
19 studies in total 
included in synthesis 
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Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.emphasized the training of county, township, and village health
workers at different levels and the importance of the integration
of hepatitis B vaccination into the government immunization
plan.
Provincial Projects
System-Oriented Interventions
Among the 14 studies focusing on provincial projects, 4
reported health system interventions and specifically effect of
out-of-cold chain strategies. Lin et al,34 Wang et al,36 and Zhang
et al37 divided the target population into 3 groups randomly. In
the control group, hepatitis B vaccine was provided in
ampoules, stored in cold chain, and administered with AD
syringes to infants in facilities. In the ampoule outside the cold
chain group, vaccine was stored out of the cold chain and
administered by the help of village-based health workers to
infants born at home. In the hepatitis B-Uniject outside the cold
chain group, vaccine was packaged in a prefilled injection
device and other strategy was the same as the trial group.36
Sun et al35 used similar strategy but divided the participants into
5 groups, including: Uninject group used cold chain for the
hepatitis B vaccine which was delivered by township health
workers; Uninject group 2 delivered the vaccine by local
doctors out of the cold chain; control groups all delivered
the vaccine with cold chain while in group 1 vaccine was
injected by local doctors with 5 CNY financial subsidy, in
group 2 vaccine was injected by township health workers with 5
CNY financial subsidy, and in group 3 vaccine was delivered by
nurses or township health workers in hospitals without
financial subsidy.
Patient/Community-Oriented Interventions
One study evaluated a patient/community-oriented inter-
vention. Li et al38 analyzed the effect of health education on
improving the TBD coverage of hepatitis B in rural and
pasturing areas in Qinghai Province. Interventions included
FIGURE 1. Flow diagram of study search and selection process.distribution of multilanguage posters, pictures, booklets and
leaflets in the community, broadcast of educational films during
traditional religious congregation, and health education in the
www.md-journal.com | 9
clinics or at home on the immunization schedule for those
registered pregnant women.
Multiple Levels
The other 9 provincial level studies (6 before-and-after
studies and 3 program evaluations) reported on multiple strat-
egies to improve coverage of HBV vaccination. Usually system-
oriented interventions were combined with provider-oriented
strategies since health system would always affect the way
heath care was delivered. In some projects, all the 3 levels of
strategies were combined together.
Among the 9 studies, 6 mentioned patient-oriented strat-
egies while 5 mentioned system-oriented strategies. Com-
munity education was the most common intervention in the
included studies, usually combined with other interventions as a
basic strategy. Chen et al,22 Gao et al,24 Gou and Qi,25 Guan
et al,26 Han et al,27 and Qi et al30 all mentioned strategies to
raise public awareness. For example, using rural radio stations
to publicize knowledge, creating simple and appealing edu-
cational literature, posters, and interactive materials.
For families living in remote and rural areas, the TBD rate
was quite low because of the difficulty in accessing health care
facilities for hospital birth. Chen et al22 developed a centralized
registration and management system for pregnant women, while
Han et al,27 Hu et al,28 Qi et al,30 and Yvan et al31 mentioned
outreach programmes in which vaccinators in rural areas
actively vaccinate the infants. Usually village doctors collabo-
rated with the outreach vaccinators to take registered of the
pregnant women and reported the probable place and timing of
the delivery to rural hospitals to help organizing for early
notification of the delivery. At the time of birth, vaccinators
were identified to fetch the vaccine stored locally and immedi-
ately administer it at home births. In that way, the local clinics
can manage the information of the pregnant women and vacci-
nate the infant either in the facility or at home with the help of
village doctors. These interventions were most successfully
implemented in prefectures with highest proportion of home
births but received less attention where hospital births were
more common.31
To assure full and sustainable access of the recommended
hepatitis B vaccination, the MoH issued a number of regulations
to improve the management of the vaccination service, especi-
ally in the institutions that deliver new-borns. Yvan reported
the regulation requiring ‘‘who delivers the infant, who has
to vaccinate the infant’’ to assure have designated persons to
provide TBD.31
Among the 9 provincial level studies, 5 involved provider-
oriented interventions. Training was used to improve health
care providers’ knowledge and awareness of vaccination;
various types of training were used.31,32 Chen et al22 and
Gou and Qi25 also trained government officials and community
leaders as well as healthcare providers. To fully mobilize
health care workers, some programs provided subsidies to
village doctors, midwives, and vaccinators to encourage them
to implement vaccines at home births.27,31 The China MoH
provided incentives to pregnant women to give birth in hospital
according to the policy issued in 2009, and there were 2 studies
specifically mentioned this policy. Yvan et al31 mentioned that
the increase in the proportion of hospital deliveries was a key
determinant of the improvement of TBD coverage, and Han
Wang et alet al27 described the subsidy provided to the pregnant women
for facility birth by implementing New Cooperative Medical
policies.
10 | www.md-journal.comIMPACT OF THE INTERVENTIONS
Here, we provide a summary of the available data on
impact of the interventions on vaccine coverage. Because of
the variability in the type of studies, interventions and outcome
measures reported in the included studies, the impact data were
also presented by the type of intervention (see Table 3).
Health System Interventions
Among the 4 studies focusing on the out-of-cold chain
strategy, three35–37 only reported the increase of the TBD rate of
hepatitis B vaccination as an outcome, while Lin et al34 reported
the coverage of the 3 doses as well as the TBD rate. After the
implementation of the intervention, coverage of the birth dose
of hepatitis B vaccine administered on time increased in all
groups while the hepatitis B-Uniject outside the cold chain
group showed the highest TBD coverage increase. Coverage
rate was much higher in the out-of-cold chain group than the
normal group with P< 0.05 for differences between each of
the groups, especially among infants born at home.36 All the
4 studies affirmed the effect of the out-of-cold chain strategy
and emphasized that the additional use of hepatitis B-Uniject
device could further improve the coverage of vaccination out of
cold chain.
Patient/Community-Oriented Interventions
In Qinghai Province, after the 1 year education project
from 2004 to 2005, the TBD rate of hepatitis B vaccination
increased by 32% from 42.61% to 75.02% after the program,
among which the TBD rate of infants born at home increased
from 19.58% to 59.56% while the awareness of the importance
of TBD among the parents also increased by about 40% than the
base investment.38 The result showed the positive correlation
between the knowledge level of the community and the imple-
mentation of the vaccination.
Multiple Levels
Since most of the included studies used more than 1 type of
intervention, we summarized the overall result of the projects.
Two studies described the impact of the China GAVI
project implemented since 2002.14,29 Through the project, the
85% hepatitis B3 coverage goal was reached in 98% of GAVI
China project counties, the 75% TBD coverage goal was
reached in 80% of GAVI project counties, and AD syringes
were introduced into 100% of GAVI-supported areas.29 This
project also impacted the national policy decisions as the MoH
issued a number of key policies and regulations that assured full
and sustainable access to the recommended hepatitis B vaccine
series for all infants upon initial implementation and during the
GAVI project.
Three studies evaluated the progress of national projects
during different time periods.15,23,33 Cui et al (2007) compared
the 2 national vaccination coverage surveys. The result indi-
cated that estimated 3-dose hepatitis B coverage increased
substantially overall, from 70.7% among children born in
1997 to 89.8% among children born in 2003, while timely
hepatitis B birth-dose coverage also increased by more than
46% (29.1% in 1997 to 75.8% in 2003).23 Liang et al15
described the result of the national serosurvey and concluded
that hepatitis B vaccine coverage (3 doses) increased by 63.4%
Medicine  Volume 95, Number 19, May 2016(from 30.0% for children born in 1992 to 93.4% for children
born in 2005) while receipt of a TBD increased from 22.2% to
82.6% for children born during this interval. Zhou et al33
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
reviewed the implementation of mass vaccination of hepatitis B
vaccine from 1980 to 2008 and stated that the overall coverage
of hepatitis B vaccine in infants has increased steadily and
reached more than 95.0% in urban and 97.0% in rural areas.
The all last 9 studies used a series of strategies including at
least 2 levels of intervention. All the projects reported signifi-
cant increases in the coverage of hepatitis B vaccination. The
TBD coverage reached a level ranging from 67% to over 95%
from the baseline level ranging from 44% to 75%. Seven studies
also reported the increase of the TBD coverage among infants
born at home. The result indicated that although in most studies
the TBD coverage reached a level of 60% to 80%, there was still
challenge for this kind of population since in some rural areas
the TBD coverage only increased from 9% to 14% to about
29%.26,31
FACTORS INFLUENCING THE IMPLEMENTATION
OF HEPATITIS B VACCINATION
Among the included studies, the 3 reviews14,29,33 and
5 program evaluations15,22,23,31,32 described the factors influen-
cing the success of the vaccination implementation directly,
while in cluster randomization trials34–37 or before-and-after
studies24–28,30,38 we collected the impact factors mainly from
the result and discussion sections. We categorized factors into
those related to the recipients of care, health systems con-
straints, and the influence of the social and political context
in China.
Recipients of Care
We identified several factors related to how communities,
parents, and family members perceive policies and interven-
tions to promote hepatitis B vaccination, including awareness
and knowledge about the disease and accessibility of health
services and facilities (see Table 4).
The knowledge of communities, especially parents, about
the transmission of hepatitis B virus, the importance of hepatitis
B vaccine, immunization procedures, and related supporting
policies was an important impact factor to promote the vaccina-
tion among the infants. Many studies24–27,30–32,37,38 indicated
that besides financial barriers to vaccination, a lack of aware-
Medicine  Volume 95, Number 19, May 2016ness about hepatitis B and prevention through vaccination
was the main barrier to improving coverage. Several papers
advocated for community-based information, education, and
TABLE 4. Recipients of Care: Factors Affecting the Implementati
Awareness and
knowledge
Parents’ knowledge about the policy and impo
with the timely birth dose coverage and t
Some cultural taboos such as forbidden the
Culturally and linguistically appropriate, rel
modules, and survey questionnaires
Accessibility to The timely birth dose rate was higher in the
health services The residents living at the remote areas can
and facilities Subsidized pregnancy and childbirth care th
reduced or eliminated hospital charges
The help of village doctors in reaching the pre
at home
The help of religious leaders and education w
different ethnic groups
Project management conducted at the local l
community was extremely helpful for nav
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.communication activities to facilitate the implementation of
the hepatitis B vaccination in line with the government
policy.24,25,27,28,30,32 During community education, some
studies emphasized that if the language used was too complex,
marginalized populations may be missed so culturally and
linguistically appropriate, educational materials, training
modules, could help improve the impact of community
education.22,31,38
It has been reported that increases in TBD rate of hepatitis
B vaccination highly corresponded to increased facility birth
rate in China.24–27,31,35 The TBD rate was higher in the areas
where the facility birth rate was high. For example, the National
Epidemiological Serosurvey of Hepatitis B in 2006 indicated
that during 2002 to 2005 in 31 provinces, birth dose coverage
rates were highest (84%) among children born in county level
hospitals and a lower rate was observed in children who were
born in township hospitals (78%) while coverage rates among
children born at home were only 31.4%.15 However, it is more
difficult for poor families in rural areas to access health facilities
for childbirth,31,34 which can influence the coverage of timely
first dose of hepatitis B vaccine, and demand for routine
childhood vaccinations more generally. To address this, the
government initiated subsidized pregnancy and childbirth care
through the National New Rural Cooperative Medical Insur-
ance, which reduces or eliminates hospital charges.15,24,28,29
Some studies indicate that the coverage of hepatitis B vaccina-
tion increased along with the increase of facility birth rate.
The main barriers for neonatal vaccination were difficulty
in access to health care service in rural and remote areas where
many pregnant women gave birth at home. As a result, to ensure
vaccination coverage rate of infants born at home, the health
care providers also used out-reach programs to vaccinate neo-
nates at home, in which the village doctors played an important
role in reaching the pregnant women in remote areas and help
vaccinating infants born at home in time.15,27,28,30,32,34–37 But
some studies also highlighted the influence of customs and
cultural taboos on parents’ acceptance of the vaccine for their
newborns.26,27,30,36 For example, in some areas inhabited by
minority ethnic groups (e.g., Zang or Yi), ‘‘strangers,’’ which
were people outside of the immediate family were forbidden to
see newborn infants within a month; this impacts on community
Experiences in China’s Hepatitis B Vaccination Implementationhealth workers’ ability to conduct home visits for timely
vaccination of infants.26 In 1 study conducted in Chengkou
County, a remote area in Chongqing City, the long-lasting
on of Interventions
rtance of hepatitis B immunization program has positive correlation
he main barrier is their unawareness
strangers to see the infants within a month was a barrier
evant, and potentially effective educational materials, training
areas where the facility birth rate was high
hardly give birth in facilities
rough the National New Rural Cooperative Medical Insurance
gnant women in remote areas was essential to vaccinate infants born
ere combined with religious folk activities were important to reach
evel by an experienced and trusted member of the local health care
igating implementation
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preference for sons persists made women inferior in social
position and pregnant women could rarely get support from
their families to give birth in a facility, which limits the
opportunity for infants born in this area to receive a timely
first dose of hepatitis B vaccine.27 As a result, in some minority
areas, the education to the community and the outreach pro-
grams were based on the motivation of religious leaders in order
to reach different ethnic groups, and education was commonly
combined with religious folk activities.28,38 Chen et al22
reported that project management conducted at the local level
Wang et alby an experienced and trusted member of the local health care
community was extremely helpful for the implementation of the
interventions in Haimen City and its villages.
Health System Constraints
We identified several aspects of the health system that
constrain the implementation of strategies to increase hepatitis
B vaccination coverage in China. We found factors relating to
supply and procurement of vaccines, knowledge and motiv-
ations of health care workers, monitoring and supervision of
programmes, and effective management and cooperation
seemed to increase vaccine coverage (see Table 5).
The regular supply of essential vaccine and injection
equipment was highlighted in many papers as important for
the implementation of hepatitis B vaccination.15,23,26,29,31–35,37
The quality and the price of the vaccine both impact on avail-
ability. The evaluation of the GAVI China project showed that
domestic procurement of hepatitis B vaccine and AD syringes,
which stimulated national vaccine production and ensured a
continuous supply and low prices, was central to programme
sustainability.29 In some rural areas, poor availability of the
vaccine in village clinics was an obstacle to the improvement in
coverage rates, especially the TBD at home.31
Combining the intervention with usual health care projects
or procedures could help accomplish the program goals. Some
studies26,30 indicated that including the vaccination in normal
clinical routines can improve the vaccination rate in facilities.
Hu et al28 reported the positive impact of combining the
promotion of hospital birth with the existing reducing maternal
mortality and eliminating neonatal tetanus project. This is
TABLE 5. Health System Factors Affecting the Implementation o
Supply and procurement Ensure the local supply of hepatitis B
health-care facilities
Registration system to screen and ma
Combine the intervention with the no
Knowledge and motivations
of health care workers
Hepatitis B related knowledge and ski
were important
Training through projects to enhance
among health-care workers through
Dedication and responsibilities of hea
System of rewards and
punishments
Repeated supervision visits focusing
systematically eliminate them throu
Provide village doctors, midwives, and
subsidies
Management and
cooperation
Involving key stakeholders at the begin
for the organization and manageme
Establish communication and coopera
hospitals, centers for disease contro
Paperwork or written-down protocol
12 | www.md-journal.comespecially helpful for governments which aim to introduce a
new intervention or project into the areas.
The knowledge and skills of the health care providers can
affect the vaccination coverage in facilities. According to Guan
et al,26 Qi et al,30 and Wang et al,36 the coverage surveys
revealed that because of the lack of knowledge of the vaccine
about its indication and contraindication, some health workers
were reluctant to give the vaccine birth dose to infants perceived
to be sick, weak, or of low birth weight.36 Training to enhance
the awareness of staff at all levels could help increase the
knowledge among health-care workers and improve the vacci-
nation coverage.25,26,29–32,37 Besides skills and knowledge,
Zhou et al33 concluded that dedication of healthcare workers
was one of the most critical factors for the achievement China
had made in increasing the coverage of hepatitis B vaccination;
Han et al27 also described the importance of the motivation of
the local vaccinators in the accomplishment of home visits.
A well-defined system of rewards and punishments for
performance of health care workers was found to be an essential
guarantee of implementation of HBV vaccine. Many studies
reported that repeated and regular supervision visits focusing on
low-performing areas could identify the remaining roadblocks
and systematically eliminate them through feedback so as to
ensure implementation.25,28–31,37 In different levels, the fre-
quency and form of supervision could be various. In most cases,
the monitoring would follow a top-down procedure in which the
upper levels of government health care workers supervise the
lower level. The accomplishment of the goals to improve the
vaccination coverage would feedback to the upper level and is
used as part of assessment of the officials.25,28 Besides, Sun
et al35 enhanced the importance of providing village doctors,
midwives, and doctors who participated in outreach vaccination
with appropriate subsidies. Since the local health care workers
mainly work in the low-income areas, economic incentives can
greatly improve the motivation of the local doctors in partici-
pating in the vaccination programs.23,27,31,35
A communication and cooperation mechanism between
maternity and child care institutions, hospitals, centers for
Medicine  Volume 95, Number 19, May 2016disease control (CDC), and other government departments
was also important. Some studies indicated that written proto-
cols could encourage better cooperation among project
f Interventions
vaccination, effective injection equipment, and the quality of
nage pregnant women/infants, especially migrant population
rmal health care projects or procedures
lls of health care providers, health officials, and community leaders
the professional level of staff at all levels and knowledge increased
training
lthcare workers are critical
on low-performing areas identified remaining roadblocks to
gh feedback and ensure implementation uniformity
doctors who participated in outreach vaccination with appropriate
ning of the project and make responsibilities of each personnel clear
nt of the project was critical for successful implementation
tion mechanism between maternity and child care institutions,
l, and other government department was important
to guarantee strong cooperation among stakeholders
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stakeholders.29 Critical to the management of programs and
projects to promote hepatitis B vaccination was the involvement
of key stakeholders at project inception and being clear about
roles and responsibilities of cooperating organizations, services,
and personnel.14,22,25,28–30,37 The stakeholder in management
could help push the process of the intervention implementation
and gain success in reaching out to the targeted population.
Maintained communication with the government and public
health officials could also facilitate policy changes based on
current and forthcoming project data.22 Kane et al14 also noted
that the success of GAVI China project was because of the close
work between China Expanded Program on Immunization and
the vast network of CDC staff at different levels.
Social and Political Context
We identified several factors related to the health system,
including political commitment, social context and inter-
national cooperation, that influenced hepatitis B vaccination
coverage in China (see Table 6).
The influence of the central government and exceptional
political will that lead to national commitment was the key to
the success of universal vaccination in China.14,22,29,31,33 In
1992, the former MoH of China decided to use hepatitis B
vaccine routinely for neonates as a part of China’s Planned
Vaccination Program and issued the Implementation Plan of the
National Hepatitis B Vaccination which standardized the imple-
mentation of hepatitis B vaccination.33 In 2001, the State
Council had approved a statement from the MoH and the
Ministry of Finance that hepatitis B vaccine was to be integrated
into routine Expanded Program on Immunization throughout
the China; this was a milestone for the improvement of uni-
versal hepatitis B vaccination rate. Without the influential group
of forward thinking leaders from both the China CDC and the
MoH advocating the process, however, the hepatitis B would
not have been included into the immunization programs in
China so readily.29 The success of GAVI China can also be
attributed in part to national government commitment and the
support of the central and local government departments.14
Some studies also mentioned the importance of policies
and laws in providing standardized services.14,15,23,29,31,33 The
China government enacted a series of legislations, laws, regu-
lations, and guidelines to promote hospital birth, to require
obstetric nurses to administer the birth dose of hepatitis B
vaccine within 24 hours after birth, and to eliminate vaccination
fees. Both the National Plan of Prevention of Hepatitis B from
Medicine  Volume 95, Number 19, May 20162006 to 2010 and the Expanded National Immunization Pro-
gram Management Plan recommended timely first dose within
24 hours of birth. Those legislations and laws became not only
TABLE 6. Social and Political Factors Affecting the Implementati
Political commitment The will of influential people and the suppo
The exceptional political will and national c
Social context Legislations, laws, regulations, guidelines to
to administer the birth dose of hepatitis B va
Infant hepatitis B vaccination was added to
International The funding support of donor policies and i
cooperation Additional government funding could contrib
project management, supervision, and mo
The availability of support from the Global A
combination with new central and provinc
opportunity, as well as a management stru
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.the guideline for the health workers to implement the interven-
tions, but also the legal ground that the end users could rely on
for demanding health care information, service, and economic
support. These policies greatly helped improve the accessibility
to health service and the quality of health care.
Another important factor that facilitated the implementa-
tion of hepatitis B vaccination was additional government
funding combined with financial support from donors and
international program/organizations.14,22,23,29 In 2002, hepatitis
B vaccination of infants was fully integrated into the routine
immunization programme and the Government of China part-
nered with the GAVI to provide free vaccine to western and
poor areas while provincial financial departments also provided
necessary funding to cap user fees to ensure affordability. GAVI
offered $76 million budget with an equal amount of Chinese
Government to cover the cost of AD syringes and vaccine in
remote areas in China.14 That funding support helped the
inception and spread of the vaccination at the beginning and
the realization of eliminate the vaccination and administration
cost. Meanwhile, the sustainability of the project also relied on
the ongoing financial input of the government in different
levels, which contributed in the ability of Chinese government
to take over the responsibility from the international organiz-
ations. By 2005, the State Council promulgated the regulations
on the administration of vaccine circulation and implementation
which stated that the vaccine should be provided completely
free of charge nationally. The government additional funding
contributed to support new training needs, information and
communication, project management, supervision, and
monitoring. It also covered the subsidies for local health care
workers and greatly enhanced the enthusiasm of grass-roots
health care workers. What is more, the availability of support
from GAVI for hepatitis B vaccination in combination with new
central and provincial government level funds from China
provided not only the financial and political opportunity but
also a management structure.14
DISCUSSION AND CONCLUSION
This review systematically collected and assessed effects
of interventions on improving infants’ uptake of hepatitis B
vaccination, and focused on summarizing the factors that
influenced implementation of the interventions. Overall, we
found that although there are many studies assessing the effect
of hepatitis B vaccination, number of original studies exploring
the reasons for success are limited.
Experiences in China’s Hepatitis B Vaccination ImplementationThe study designs used to evaluate impact of different
interventions to improve coverage of hepatitis B vaccination
varied, so meta-analysis was not feasible for the synthesis of the
on of Interventions
rt of the central or local government
ommitment
promote hospital birth, require obstetrical nurses who deliver babies
ccine within 24 hours after birth, and elimination of vaccination fees
China’s National Immunization Programme
nternational program/organizations
ute to support new training needs, information and communication,
nitoring
lliance on Vaccine and Immunization for hepatitis B vaccination in
ial level funds from China provided the financial and political
cture
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evidence. The interventions used in the included studies were
categorized into health system-oriented, provider-oriented, and
patients/community-oriented level. All the included studies
reported that interventions increased the coverage of hepatitis
B vaccination of newborns, especially the birth dose of hepatitis
B vaccination which is the most important dose for preventing
mother to child transmission of HBV infection. Although
studies generally showed that vaccination coverage in the
subgroup of infants born at home increased to a greater extent
than in the whole population, which indicates that the outreach
intervention has bigger influence on the disadvantaged groups.
We found evidence from the included studies that com-
munity education was the most frequently used intervention. All
studies indicated the importance of increasing the awareness of
the public, especially pregnant and women of reproductive age,
and their families. Since hospital birth was the most essential
factor which determined the coverage of the vaccination in the
whole population, public education about knowledge of HBV or
hepatitis B vaccination was usually combined with the pro-
motion of hospital birth in rural areas. It also showed evidence
from the included studies that it was more effective to put the
relevant interventions together with the current maternal health
promotion programs.
To improve the accessibility to the health care service, the
former MoH issued a circular on further strengthening facility
birth services in rural areas which aimed at improving facility
birth rate in rural areas and TBDs of hepatitis B vaccination in
2009. Meanwhile, some studies would use out-reach programs
to cover the home-birth infants. Out-of-cold chain strategy was
more effective in increase the coverage of vaccination in the
remote area where the facility birth rate was respectively low. In
this kind of programs, the help of local health workers and
religious leaders were the most important facilitators in the
implementation. In China, hepatitis B vaccination services are
usually provided by community-based health workers in both
rural and urban areas. So strengthening of the knowledge and
skills training, and setting up appropriate accountability and
necessary incentives and/or punishments mechanisms can
promote the dedication and ensure the active participation of
community-based health workers.
Besides all the interventions or vaccination campaigns, the
essential impact factors were political and social factors and the
system reinforcement. The strong government commitment and
the cooperation of the different government departments were
Wang et althe basic of the policy making and the smooth implementation
of the programs. So, it was important to involve the key
stakeholders in making the legislation and guidelines.
POTENTIAL LIMITATIONS OF THE REVIEW
None of the included studies were strict double-blind
randomized trial considering the ethnic principle because there
had been enough evidence on the effectiveness of infant immu-
nization. Since all the programs used more than 1 intervention
and were influenced by factors in different levels, it is difficult
to access which interventions worked best and which were the
most effective. It was also difficult to tell which factors played
the most important role in the implementation of the program.
In other systematic reviews which tried to summarize the
effectiveness of health promotion interventions, the same kind
of problems also occurred.39 It was believed that no single
magic bullet intervention exists and significant changes were
made because of all interventional programs were integrated
in nature.
14 | www.md-journal.comWe did not locate any qualitative research reporting in
detail why different interventions might or might not have
improved the coverage of the hepatitis B vaccination. Although
we tried to find some description in the result or discussion part
of the included studies, few studies mentioned the detailed
implementation process and the obstacles or facilitators during
the process.
IMPLICATIONS FOR POLICY AND FUTURE
RESEARCH
The most important lesson from China’s experience in
increasing TBD of the hepatitis B vaccine is the integration of
hepatitis B vaccine into the national planning and the strong
implementation ability, which relies on the top-down health
system. Strategies included establishing maternal registration
system, especially strengthening tracking of migrant popu-
lation, out-reach interview in remote areas, mobilization of
facility birth, and facility birth incentives for poor areas. This
could be an important component of vaccination programmes in
low and middle income countries, integrating important and
urgent health measures into the government agenda can facili-
tate large-scale interventions.
Necessary policy and regulation with additional govern-
ment funding could contribute to support procurement of the
vaccine, and ensuring equipment and subsidies to grass-root
health care workers. This strategy is essential to improve
vaccination coverage among the poor, especially the migrant
population. Meanwhile, free services are an important measure
to address the accessibility of hepatitis B vaccination and can
enhance the health care receivers’ approval and acceptance,
which helps achieve the policy goals.
Appropriate service delivery is the key to China’s hepatitis
B vaccination. Raising facility birth rate was one of the key
measures for the improvement of vaccination coverage. In
remote areas, however, where faced with difficulties in facility
birth, the door-to-door vaccination service became an effective
support measure. Invest in out-of-cold chain storage and trans-
portation equipment should also be taken into consideration.
Better health information systems can be managed by village
doctors so that vaccine can be delivered at home to increase the
TBD rate of infants born at home. The economic conditions and
health infrastructure varies largely in low and middle income
countries, so services should be adapted to local contexts. Also,
Medicine  Volume 95, Number 19, May 2016with challenges of health human resource in developing
countries, government should focus more on the promotion
of grass-roots health human resource capacity and enthusiasm.
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